A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis
P Coto-Segura, C Segú-Vergés, A Martorell… - Frontiers in …, 2023 - frontiersin.org
Background Psoriasis is a chronic immune-mediated inflammatory systemic disease with
skin manifestations characterized by erythematous, scaly, itchy and/or painful plaques …
skin manifestations characterized by erythematous, scaly, itchy and/or painful plaques …
[PDF][PDF] Complex treatment the patients with psoriasis and concomitant activated herpes virus infection, types 1, 2
UV Fedorova, OO Syzon, MO Dashko, IY Voznyak - Wiad Lek, 2020 - wiadlek.pl
The aim: Is to increase effectiveness and assess safety of the antiviral therapy in complex
treatment of patients with psoriasis with activated chronic herpes virus infection of types 1 …
treatment of patients with psoriasis with activated chronic herpes virus infection of types 1 …